MedicalResearch.com Interview with Matthew H. Taylor, M.D., Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR

Previous
Previous

Dr Taylor on Preliminary Efficacy and Safety Data for IO-108 in Advanced Solid Tumors

Next
Next

IO-108 Demonstrates Safety and Efficacy in Advanced Solid Tumors